Feuer EJ - Search Results

1

Modeling the dissemination of mammography in the United States.

Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ. Cronin KA, et al. Among authors: feuer ej. Cancer Causes Control. 2005 Aug;16(6):701-12. doi: 10.1007/s10552-005-0693-8. Cancer Causes Control. 2005. PMID: 16049809

2

How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach.

Feuer EJ, Wun LM. Feuer EJ, et al. Am J Epidemiol. 1992 Dec 15;136(12):1423-36. doi: 10.1093/oxfordjournals.aje.a116463. Am J Epidemiol. 1992. PMID: 1288272

3

The increasing incidence of breast cancer since 1982: relevance of early detection.

Miller BA, Feuer EJ, Hankey BF. Miller BA, et al. Among authors: feuer ej. Cancer Causes Control. 1991 Mar;2(2):67-74. doi: 10.1007/BF00053123. Cancer Causes Control. 1991. PMID: 1873438

4

Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States?

Wun LM, Feuer EJ, Miller BA. Wun LM, et al. Among authors: feuer ej. Cancer Causes Control. 1995 Mar;6(2):135-44. doi: 10.1007/BF00052774. Cancer Causes Control. 1995. PMID: 7749053

5

Risk-adjusted cancer-incidence rates (United States).

Merrill RM, Feuer EJ. Merrill RM, et al. Among authors: feuer ej. Cancer Causes Control. 1996 Sep;7(5):544-52. doi: 10.1007/BF00051888. Cancer Causes Control. 1996. PMID: 8877053

6

Confidence intervals for directly standardized rates: a method based on the gamma distribution.

Fay MP, Feuer EJ. Fay MP, et al. Among authors: feuer ej. Stat Med. 1997 Apr 15;16(7):791-801. doi: 10.1002/(sici)1097-0258(19970415)16:7<791::aid-sim500>3.0.co;2-#. Stat Med. 1997. PMID: 9131766

7

A semi-parametric estimate of extra-Poisson variation for vital rates.

Fay MP, Feuer EJ. Fay MP, et al. Among authors: feuer ej. Stat Med. 1997 Nov 15;16(21):2389-401. doi: 10.1002/(sici)1097-0258(19971115)16:21<2389::aid-sim683>3.0.co;2-j. Stat Med. 1997. PMID: 9364649

8

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.

Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. Legler JM, et al. Among authors: feuer ej. Cancer Causes Control. 1998 Oct;9(5):519-27. doi: 10.1023/a:1008805718310. Cancer Causes Control. 1998. PMID: 9934717

9

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.

Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Etzioni R, et al. Among authors: feuer ej. J Natl Cancer Inst. 1999 Jun 16;91(12):1033-9. doi: 10.1093/jnci/91.12.1033. J Natl Cancer Inst. 1999. PMID: 10379966

10

Permutation tests for joinpoint regression with applications to cancer rates.

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Kim HJ, et al. Among authors: feuer ej. Stat Med. 2000 Feb 15;19(3):335-51. doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. Stat Med. 2000. PMID: 10649300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page